• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Reversion of a human tumour cell line containing oncogenic p21ras is associated with a defect in the post-translational processing of the ras protein.

作者信息

Tilbrook P A, Paterson H F, Marshall C J

机构信息

Institute of Cancer Research, Chester Beatty Laboratories, London, UK.

出版信息

Oncogene. 1995 Feb 16;10(4):805-9.

PMID:7862461
Abstract

Correct post-translational modifications of the ras proteins are essential for their membrane localisation and functioning. The flat revertant cell lines 1aCB and 8b, derived from the human bladder carcinoma cell line EJ, contain the transforming gene V12Ha-ras and are resistant to retransformation by ras protein or DNA, but still do require the presence of ras for proliferation. Both revertant cell lines demonstrated reduced levels of membrane associated p21ras when compared to their parental EJ cell lines. This reduced level in 1aCB was reflected by an increase in nuclear associated p21ras, as seen by immunofluorescence of endogenous and introduced ras. In addition, 1aCB had a reduced ratio of ras in the detergent to aqueous phases after triton X114 partitioning, suggesting a defect in Step I processing of the p21ras in the cell line. This was not however due to defects in the Step I enzymes farnesyltransferase or carboxymethyltransferase whose activities were not reduced.

摘要

相似文献

1
Reversion of a human tumour cell line containing oncogenic p21ras is associated with a defect in the post-translational processing of the ras protein.
Oncogene. 1995 Feb 16;10(4):805-9.
2
Farnesyltransferase inhibitors block the neurofibromatosis type I (NF1) malignant phenotype.法尼基转移酶抑制剂可阻断I型神经纤维瘤病(NF1)的恶性表型。
Cancer Res. 1995 Aug 15;55(16):3569-75.
3
Inhibitors of farnesyltransferase and Ras processing peptidase.
Biochem Biophys Res Commun. 1995 Dec 26;217(3):728-32. doi: 10.1006/bbrc.1995.2833.
4
Farnesyltransferase inhibitor (L-744,832) restores TGF-beta type II receptor expression and enhances radiation sensitivity in K-ras mutant pancreatic cancer cell line MIA PaCa-2.法尼基转移酶抑制剂(L-744,832)可恢复转化生长因子-β II型受体表达,并增强K-ras突变型胰腺癌细胞系MIA PaCa-2的辐射敏感性。
Oncogene. 2002 Nov 7;21(51):7883-90. doi: 10.1038/sj.onc.1205948.
5
Inhibition of the prenylation of K-Ras, but not H- or N-Ras, is highly resistant to CAAX peptidomimetics and requires both a farnesyltransferase and a geranylgeranyltransferase I inhibitor in human tumor cell lines.抑制K-Ras的异戊二烯化,而非H-Ras或N-Ras的异戊二烯化,对CAAX肽模拟物具有高度抗性,并且在人肿瘤细胞系中需要法尼基转移酶和香叶基香叶基转移酶I抑制剂两者共同作用。
Oncogene. 1997 Sep;15(11):1283-8. doi: 10.1038/sj.onc.1201296.
6
Protection against malignant conversion in SENCAR mouse skin by all trans retinoic acid: inhibition of the ras p21-processing enzyme farnesyltransferase and Ha-ras p21 membrane localization.全反式维甲酸对SENCAR小鼠皮肤恶性转化的防护作用:对ras p21加工酶法尼基转移酶的抑制及Ha-ras p21膜定位的影响
Mol Carcinog. 1996 Sep;17(1):13-22. doi: 10.1002/(SICI)1098-2744(199609)17:1<13::AID-MC3>3.0.CO;2-L.
7
Altered post-translational processing of p21ras oncoprotein in a transformation-suppressed cell line.转化抑制细胞系中p21ras癌蛋白翻译后加工的改变。
Oncogene. 1991 Jul;6(7):1211-8.
8
Farnesyltransferase activity and mRNA expression in human skin basal cell carcinomas.人皮肤基底细胞癌中的法尼基转移酶活性及mRNA表达
Biochem Biophys Res Commun. 1996 Mar 27;220(3):795-801. doi: 10.1006/bbrc.1996.0483.
9
Elevation of alpha2(I) collagen, a suppressor of Ras transformation, is required for stable phenotypic reversion by farnesyltransferase inhibitors.法尼基转移酶抑制剂诱导稳定的表型逆转需要α2(I)胶原蛋白(一种Ras转化的抑制剂)的升高。
Cancer Res. 1999 May 1;59(9):2059-63.
10
Antitumor effect of a farnesyl protein transferase inhibitor in mammary and lymphoid tumors overexpressing N-ras in transgenic mice.法尼基蛋白转移酶抑制剂对转基因小鼠中过表达N-ras的乳腺和淋巴瘤的抗肿瘤作用
Cancer Res. 1998 Mar 15;58(6):1253-9.

引用本文的文献

1
Interaction Between Mevalonate Pathway and Retinoic Acid-Induced Differentiation.甲羟戊酸途径与视黄酸诱导分化之间的相互作用
J Biomed Biotechnol. 2001;1(3):108-113. doi: 10.1155/S1110724301000183.